A kosaram
0
MÉG
5000 Ft
a(z) 5000Ft-os
szállítási
értékhatárig
Ginop popup ablak bezárása

New antidiabetic drugs

Szerkesztő
London
Kiadó: Smith-Gordon and Company Limited-Nishimura Company Limited
Kiadás helye: London
Kiadás éve:
Kötés típusa: Varrott keménykötés
Oldalszám: 295 oldal
Sorozatcím:
Kötetszám:
Nyelv: Angol  
Méret: 25 cm x 17 cm
ISBN: 1-85463-017-2
Megjegyzés: Fekete-fehér ábrákkal.
Értesítőt kérek a kiadóról

A beállítást mentettük,
naponta értesítjük a beérkező friss
kiadványokról
A beállítást mentettük,
naponta értesítjük a beérkező friss
kiadványokról

Előszó

Tovább

Előszó


Vissza

Fülszöveg


mlBIm antidiabetic drugs } :
New antidiabetic drugs is a comprehensive review of recent developments in the search for new and improved treatments .for diabetes mellitus. Those involved in diabetes research and diabetic patient care will appreciate the need for new therapeutic initiatives to improve glycaemic control. This book provides a unique and authoritative evaluation of progress in the design and testing of novel compounds with hypoglycaemic activity.
.The volume opens with a timely reappraisal of the purpose and value of glycaemic control in diabetes, and considers the efficacy and limitations of existing therapies. Specific targets for new drugs are identified, and methods for screening and preclinical testing are discussed.
The majority of the text is devoted to the critical examination of new hypoglycaemic compounds. There are 25 chapters written by an international cast of experts from universities, hospitals and industrial research organizations. If you wish to... Tovább

Fülszöveg


mlBIm antidiabetic drugs } :
New antidiabetic drugs is a comprehensive review of recent developments in the search for new and improved treatments .for diabetes mellitus. Those involved in diabetes research and diabetic patient care will appreciate the need for new therapeutic initiatives to improve glycaemic control. This book provides a unique and authoritative evaluation of progress in the design and testing of novel compounds with hypoglycaemic activity.
.The volume opens with a timely reappraisal of the purpose and value of glycaemic control in diabetes, and considers the efficacy and limitations of existing therapies. Specific targets for new drugs are identified, and methods for screening and preclinical testing are discussed.
The majority of the text is devoted to the critical examination of new hypoglycaemic compounds. There are 25 chapters written by an international cast of experts from universities, hospitals and industrial research organizations. If you wish to keep pace with current events and future prospects for the treatment of diabetes then this book is a must.
New drugs and novel compounds in medicine and pharmacology: 1 ISSN: 0958-9422
ISBN: 1-85463-017-2
The editors have an international reputation in diabetes research and have collaborated in many studies.
Clifford J. Bailey (left) is Senior Lecturer in the Department of Pharmaceutical Sciences at Aston University in Birmingham, and Peter R. Flatt is Professor of Biological and Biomedical Sciences at the University of Ulster in Coleraine, UK. Vissza

Tartalom


Vissza
Megvásárolható példányok
Állapotfotók
New antidiabetic drugs New antidiabetic drugs New antidiabetic drugs New antidiabetic drugs

Könyvtári könyv volt.

Állapot: Közepes
2.840 Ft
2.270 ,-Ft 20
11 pont kapható
Kosárba